Show simple item record

dc.contributor.authorRiedel, Patrícia Gabrielapt_BR
dc.contributor.authorSakai, Vitoria Fedrizzipt_BR
dc.contributor.authorToniasso, Sheila de Castro Cardosopt_BR
dc.contributor.authorBrum, Maria Carlota Borbapt_BR
dc.contributor.authorFernandes, Fernando Schmidtpt_BR
dc.contributor.authorPereira, Robson Martinspt_BR
dc.contributor.authorBaldin, Camila Pereirapt_BR
dc.contributor.authorBaldin, Cícero de Campospt_BR
dc.contributor.authorTakahasi, Anderson Yudipt_BR
dc.contributor.authorShiki, Hugopt_BR
dc.contributor.authorKrepsky, Ana Maria Rochapt_BR
dc.contributor.authorTrindade, Damasio Macedopt_BR
dc.contributor.authorMerlo, Alvaro Roberto Crespopt_BR
dc.contributor.authorRohde, Luis Eduardo Paimpt_BR
dc.contributor.authorJoveleviths, Dvorapt_BR
dc.date.accessioned2022-08-19T04:44:59Zpt_BR
dc.date.issued2021pt_BR
dc.identifier.issn1878-3511pt_BR
dc.identifier.urihttp://hdl.handle.net/10183/247403pt_BR
dc.description.abstractIntroduction: Cardiac involvement in COVID-19 can range from mild damage to severe myocarditis. The precise mechanism by which COVID-19 causes myocardial injury is still unknown. Myocarditis following administration of COVID-19 vaccines, especially those based on mRNA, has also been described. How- ever, no reports of heart failure following reinfection with SARS-CoV-2 in patients immunized with an inactivated vaccine have been identified. Case description: The patient was a 47-year-old male construction worker of African descent, with type II diabetes and a history of infection by SARS-CoV-2 in December 2020 and May 2021, confirmed by RT-PCR. He received two doses of an inactivated vaccine against COVID-19. Between the two COVID-19 episodes with positive RT-PCR, he had two episodes of bacterial lung infection. After the second episode of SARS-CoV-2 infection, he was diagnosed with severe heart failure as a sequela of myocarditis. Conclusion: It is essential to perform a thorough follow-up after infection with SARS-CoV-2 since, even with proper immunization, it is possible that the patient was reinfected and suffered severe cardiac se- quelae as a consequence. The hypothesis of an etiology associated with the use of an inactivated vaccine against COVID-19, with a potential immune enhancement mechanism following reinfection with SARS-CoV-2, cannot be rejected.en
dc.format.mimetypeapplication/pdfpt_BR
dc.language.isoengpt_BR
dc.relation.ispartofInternational journal of infectious diseases. Hamilton, ON. Vol 113 (Dec. 2021), p. 175–177pt_BR
dc.rightsOpen Accessen
dc.subjectMyocarditisen
dc.subjectCOVID-19pt_BR
dc.subjectSARS-CoV-2pt_BR
dc.subjectHeart failureen
dc.subjectMiocarditept_BR
dc.subjectVaccineen
dc.subjectInsuficiência cardíacapt_BR
dc.subjectVacinaspt_BR
dc.titleHeart failure secondary to myocarditis after SARS-CoV-2 reinfection : a case reportpt_BR
dc.typeArtigo de periódicopt_BR
dc.identifier.nrb001147099pt_BR
dc.type.originEstrangeiropt_BR


Files in this item

Thumbnail
   

This item is licensed under a Creative Commons License

Show simple item record